MX9704105A - Kit for osteoporosis treatment cycle. - Google Patents

Kit for osteoporosis treatment cycle.

Info

Publication number
MX9704105A
MX9704105A MX9704105A MX9704105A MX9704105A MX 9704105 A MX9704105 A MX 9704105A MX 9704105 A MX9704105 A MX 9704105A MX 9704105 A MX9704105 A MX 9704105A MX 9704105 A MX9704105 A MX 9704105A
Authority
MX
Mexico
Prior art keywords
kit
treatment cycle
osteoporosis treatment
osteoporosis
therapeutical
Prior art date
Application number
MX9704105A
Other languages
Spanish (es)
Other versions
MXPA97004105A (en
Inventor
Martine Gazard
Olivier Gros
Jacques Girard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX9704105A publication Critical patent/MX9704105A/en
Publication of MXPA97004105A publication Critical patent/MXPA97004105A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a kit to be used in a therapeutical cycle based on the sequential administration of tiludronic acid or one of its salts and/or solvates and calcium during 28 to 31 days, for the treatment and/or prevention of osteoporosis.
MXPA/A/1997/004105A 1994-12-06 1997-06-03 Set for use in a therapeutic treatment cycle of osteoporo MXPA97004105A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (en) 1994-12-06 1994-12-06 OSTEOPOROSIS TREATMENT CYCLE KIT
FR94/14630 1994-12-06
FR9414630 1994-12-06
PCT/FR1995/001596 WO1996017616A1 (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle

Publications (2)

Publication Number Publication Date
MX9704105A true MX9704105A (en) 1997-09-30
MXPA97004105A MXPA97004105A (en) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
FI972383A0 (en) 1997-06-05
NO972558L (en) 1997-08-05
PL320564A1 (en) 1997-10-13
JPH10509729A (en) 1998-09-22
KR980700083A (en) 1998-03-30
WO1996017616A1 (en) 1996-06-13
AU4307396A (en) 1996-06-26
ZA9510184B (en) 1996-06-11
TR199501530A1 (en) 1996-10-21
HUT77382A (en) 1998-04-28
CA2207028A1 (en) 1996-06-13
BR9509961A (en) 1997-11-25
FI972383A (en) 1997-06-05
SK68597A3 (en) 1997-11-05
CN1168634A (en) 1997-12-24
CZ175397A3 (en) 1997-10-15
AR002946A1 (en) 1998-05-27
FR2727629B1 (en) 1997-02-28
FR2727629A1 (en) 1996-06-07
EP0797444A1 (en) 1997-10-01
NO972558D0 (en) 1997-06-05
MA23737A1 (en) 1996-07-01
IL116168A0 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
UA42747C2 (en) Peptide derivatives, pharmaceutical composition and method for stimulating growth hormone releasing
GR970100477A (en) Novel formulation
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
UA41355C2 (en) Agent for treating neuro-aids
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
IL92160A0 (en) Chelants possessing ortho ligating functionality and complexes thereof
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
MX9703944A (en) Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis.
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
NZ326345A (en) Composition containing diosgenin
GR3007995T3 (en)
MX9704105A (en) Kit for osteoporosis treatment cycle.
GB9108634D0 (en) Pharmaceutical compositions
AU3108289A (en) Compositions comprising 24,25-dihydroxy-vitamin D3 and calcium for the treatment of osteoporosis in humans
UA29461C2 (en) An agent for treatment of amyloidosis, a method for treatment of amyloidosis
SI0711163T1 (en) Use of benzydamine in the treatment of pathological conditions caused by tnf
GR3022935T3 (en) Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients
EP0333490A3 (en) Composition for the treatment of hepatopathy composition for the treatment of hepatopathy
HK44597A (en) Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
SE9303740L (en) Pharmaceutical composition
IT1242026B (en) Pharmaceutical composition containing a ferro-schizokinen complex for the treatment of iron deficiency anaemia.
UA30203A (en) Way of treatment chronic mieloleykoz
GB8628357D0 (en) Chelating agents synergistic treatment